Literature DB >> 6128526

Ventricular tachycardia associated with flecainide.

K Muhiddin, A W Nathan, K J Hellestrand, S O Banim, A J Camm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6128526     DOI： 10.1016/s0140-6736(82)91238-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

2.  Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.

Authors:  K A Muhiddin; P Turner; K Hellestrand; A J Camm
Journal:  Postgrad Med J       Date:  1985-06       Impact factor: 2.401

Review 3.  Targeting ryanodine receptors for anti-arrhythmic therapy.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

4.  Fatal ventricular tachycardia in association with propafenone, a new class IC antiarrhythmic agent.

Authors:  A W Nathan; R S Bexton; K J Hellestrand; A J Camm
Journal:  Postgrad Med J       Date:  1984-02       Impact factor: 2.401

Review 5.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

Review 6.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 7.  Drug-induced torsade de pointes. Incidence, management and prevention.

Authors:  T S Faber; M Zehender; H Just
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 8.  Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  B Holmes; R C Heel
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.